Generic Name:
Tedizolid phosphate
Project Status:
Withdrawn
Therapeutic Area:
Acute bacterial skin and skin structure infections
Manufacturer:
Cubist Pharmaceuticals Canada, Inc.
Call for patient/clinician input open:
Brand Name:
Sivextro
Project Line:
Reimbursement Review
Project Number:
SR0413-000
Call for patient/clinician input closed:
Details
Submission Type:
Initial
Indications:
Acute bacterial skin and skin structure infections